Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
PT Hetzer Medical Indonesia Tbk EBITDA Margin % Related Terms
PT Hetzer Medical Indonesia Tbk EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Hetzer Medical Indonesia Tbk EBITDA Margin % Chart
PT Hetzer Medical Indonesia Tbk Annual Data
Trend
EBITDA Margin %
PT Hetzer Medical Indonesia Tbk Semi-Annual Data
EBITDA Margin %
ISX:MEDS vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, PT Hetzer Medical Indonesia Tbk's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Hetzer Medical Indonesia Tbk EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT Hetzer Medical Indonesia Tbk's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where PT Hetzer Medical Indonesia Tbk's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 816 companies in the Medical Devices & Instruments industry.
Is PT Hetzer Medical Indonesia Tbk's EBITDA Margin % too high?
PT Hetzer Medical Indonesia Tbk's current EBITDA Margin % is 0.00%. Based on the distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT Hetzer Medical Indonesia Tbk has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does PT Hetzer Medical Indonesia Tbk's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Hetzer Medical Indonesia Tbk ranks #999999 out of 816 companies for EBITDA Margin %. This places PT Hetzer Medical Indonesia Tbk in the lower half of its industry. The industry median EBITDA Margin % is 7.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PT Hetzer Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Hetzer Medical Indonesia Tbk's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Hetzer Medical Indonesia Tbk stock overvalued right now?
PT Hetzer Medical Indonesia Tbk (ISX:MEDS) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. PT Hetzer Medical Indonesia Tbk's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PT Hetzer Medical Indonesia Tbk (ISX:MEDS), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Hetzer Medical Indonesia Tbk Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MEDS has been successfully added to your 
